Horm Metab Res 2023; 55(01): 31-39
DOI: 10.1055/a-1899-8862
Original Article: Endocrine Care

Serum Calcium, Magnesium, and Phosphorus Levels in Patients with COVID-19: Relationships with Poor Outcome and Mortality

Authors

  • Juan J. Díez

    1   Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain
  • Pedro Iglesias

    1   Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain
  • Agustín García

    2   Department of Admission and Clinical Documentation, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
  • Ignacio Martín-Casasempere

    3   Subdirección General de Farmacia y Productos Sanitarios, Consejería de Sanidad de la Comunidad de Madrid, Madrid, Spain
  • Francisco A. Bernabéu-Andréu

    4   Department of Biochemistry, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
Preview

Abstract

In this retrospective study to assess the impact of serum corrected calcium (CorrCa), magnesium (Mg) and phosphorus (P) levels, all adult patients with laboratory-confirmed COVID-19 hospitalized during 2020 were included. Poor outcome was considered in patients who presented need for mechanical ventilation, intensive care unit (ICU) admission, or in-hospital mortality. We analyzed 2473 patients (956 females) aged (mean±SD) 63.4±15.9 years. During admission, 169 patients (6.8%) required mechanical ventilation, 205 (8.3%) were admitted to the ICU, and 270 (10.9%) died. Composite variable of poor outcome, defined as need for mechanical ventilation, ICU admission or death, was present in 434 (17.5%) patients. In univariate analysis, the need for mechanical ventilation was positively related to Mg levels (OR 8.37, 95% CI 3.62–19.33; p<0.001); ICU admission was related to CorrCa (OR 0.49, 95% CI 0.25–0.99; p=0.049) and Mg levels (OR 5.81, 95% CI 2.74–12.35; p<0.001); and in-hospital mortality was related to CorrCa (OR 1.73, 95% CI 1.14–2.64; p=0.011). The composite variable of poor outcome was only related to Mg (OR 2.68, 95% CI 1.54–4.68; p=0.001). However, in multivariate analysis only CorrCa was significantly related to the need for mechanical ventilation (OR 0.19, 95% CI 0.05–0.72; p=0.014) and ICU admission (OR 0.25; 95% CI 0.09–0.66; p=0.005), but not with in-hospital mortality or the composite variable. In conclusion, CorrCa can be used as a simple and reliable marker of poor outcome in patients with COVID-19, although not to predict the risk of in-hospital mortality.

Supplementary Material



Publication History

Received: 26 March 2022

Accepted after revision: 30 June 2022

Article published online:
23 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany